Skip to main content
. 2016 Oct 15;8(10):4233–4241.

Figure 3.

Figure 3

CD262+ CRC cells are more resistant to chemotherapy. (A, B) CTL, CD44+, CD133+ or CD262+ Caco-2 cells were subjected to 5-FU (A) or Cisplatin (CP, B) treatment in vitro. (C, D) CTL,CD44+, CD133+ or CD262+ T-84 cells were subjected to 5-FU (A) or CP (B) treatment in vitro. *P<0.05. N=5.